Siddhesh Joshi (Editor)

Ronald T Raines

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Nationality
  
USA

Fields
  
Chemical biology

Role
  
Professor

Name
  
Ronald Raines



Alma mater
  
Massachusetts Institute of Technology

Known for
  
Research on collagen, ribonucleases, protein chemistry, and biofuels

Notable awards
  
Helen Hay Whitney Fellow Searle Scholar Award Presidential Young Investigator Award Shaw Scientist Award Pfizer Award in Enzyme Chemistry, ACS Guggenheim Fellow AAAS Fellow Arthur C. Cope Scholar Award, ACS Emil Thomas Kaiser Award Royal Society of Chemistry Fellow Rao Makineni Lectureship Welch Lectureship Repligen Corporation Award in Chemistry of Biological Processes ACS Jeremy Knowles Award, RSC Humboldt Research Award Ralph F. Hirschmann Award in Peptide Chemistry, ACS

Education
  
Harvard University (1982–1986), West Essex High School, Massachusetts Institute of Technology

Awards
  
Guggenheim Fellowship for Natural Sciences, US & Canada

People also search for
  
Jeremy R. Knowles, Sheng Ding, Daniel M. Pinkas, Annelise E. Barron

Doctoral advisor
  
Jeremy R. Knowles

Ronald T. Raines is an American chemical biologist. He is the Firmenich Professor of Chemistry at the Massachusetts Institute of Technology.

Contents

Education

Raines graduated in 1976 from West Essex High School in North Caldwell, New Jersey. He received Sc.B. degrees in chemistry and biology at the Massachusetts Institute of Technology, doing undergraduate research with Christopher T. Walsh. He earned A.M. and Ph.D. degrees in chemistry at Harvard University with Jeremy R. Knowles, the title of his doctoral thesis being Energetics of Enzymatic Catalysis: Triosephosphate Isomerase. He was a Helen Hay Whitney postdoctoral fellow in the Department of Biochemistry and Biophysics at the University of California, San Francisco with William J. Rutter. He was a member of the faculty at the University of Wisconsin–Madison from 1989 until 2017, when he joined the faculty at MIT. He was a Visiting Associate in Chemistry at Caltech in 2009.

Career

Raines has made the following noteworthy contributions.

  • Revelation of the basis for the conformational stability of collagen, which is the most abundant protein in animals. This work led to the discovery that unappreciated chemical forces—the n→π* interaction and C5 hydrogen bond—contribute to the stability of nearly every protein. Such hyperstable collagens are in preclinical trials as wound-healing agents.
  • Discovery of how to endow an otherwise innocuous human RNA-cleaving enzyme with toxicity that is specific for cancer cells. Such a ribonuclease is in a human clinical trial as an anti-cancer agent.
  • Mechanistic Insight on cellular redox homeostasis and on imperatives for the uptake of cationic proteins and peptides by mammalian cells.
  • Invention of efficient chemical processes to synthesize proteins and to convert crude biomass into useful fuels and chemicals, and fluorogenic probes to image the uptake of molecules into living cells.
  • Raines is a founder of Quintessence Biosciences, Inc. and Hyrax Energy, Inc., and he serves on the editorial advisory boards of the journals ACS Chemical Biology; Bioconjugate Chemistry; Peptide Science; Protein Engineering, Design & Selection; and Scientific Advisory Board of the Keystone Symposia.

    References

    Ronald T. Raines Wikipedia